In connection with the implementation of the project titled “Design and development of an innovative solution – a generic drug of the GLP-1 receptor agonist class for the treatment of type 2 diabetes”,” funded from the state budget by the Medical Research Agency, ZF Polpharma S.A., you are kindly requested to submit a bid for the purchase of a serivice related to the development and delivery of reusable injector pens.
Details of the price inquiry can be found in the documents attached below.